Search

01/01/2022 Non-invasive tests for clinically significant portal hypertension after HCV cure
Semmler G., Lens S., Meyer E.L., Baiges A., Alvardo-Tapias E., Llop E., Tellez L., Schwabl P., Mauro E., Escudé L., Díez C., Ibañez-Samaniego L., Puente Á., Fortea J.I., Abadía M., Zanetto A., Conthe A., Hernandez-Évole H., Luzko Scheid I.S., Jia J., Yoshiji H., Francque S.M., Tsochatzis E.A., Russo F.P., Crespo G., Forns X., Bañares R., Villanueva C., Hernández-Gea V., Reiberger T., Bosch J., García Pagán J.C., Mandorfer M.. Non-invasive tests for clinically significant portal hypertension after HCV cure. JOURNAL OF HEPATOLOGY. 2022; 77(6)DOI:10.1016/j.jhep.2022.08.025. PMID:36063968. IF:25.700(Q1/1D).
01/01/2022 The Genetic Diversity and Dysfunctionality of Catalase Associated with a Worse Outcome in Crohn’s Disease
Iborra M., Moret I., Busó E., García-Giménez J.L., Ricart E., Gisbert J.P., Cabré E., Esteve M., Márquez-Mosquera L., García-Planella E., Guardiola J., Pallardó F.V., Serena C., Algaba-Chueca F., Domenech E., Nos P., Beltrán B.. The Genetic Diversity and Dysfunctionality of Catalase Associated with a Worse Outcome in Crohn’s Disease. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(24)DOI:10.3390/ijms232415881. PMID:36555526. IF:5.600(Q1/3D).
01/01/2022 EUS-guided gastroenterostomy versus duodenal self-expandable metal stent for malignant gastric outlet obstruction: results from a nationwide multicenter retrospective study (with video)
Sánchez-Aldehuelo R., Subtil Iñigo J.C., Martínez Moreno B., Gornals J., Guarner-Argente C., Repiso Ortega A., Peralta Herce S., Aparicio J.R., Rodríguez de Santiago E., Bazaga S., Juzgado D., González-Panizo F., Albillos A., Vázquez-Sequeiros E.. EUS-guided gastroenterostomy versus duodenal self-expandable metal stent for malignant gastric outlet obstruction: results from a nationwide multicenter retrospective study (with video). GASTROINTESTINAL ENDOSCOPY. 2022; 96(6)DOI:10.1016/j.gie.2022.07.018. PMID:35870508. IF:7.700(Q1/2D).
01/01/2022 Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)
Gallego-Durán R., Albillos A., Ampuero J., Arechederra M., Bañares R., Blas-García A., Berná G., Caparrós E., Delgado T.C., Falcón-Pérez J.M., Francés R., Fernández-Barrena M.G., Graupera I., Iruzubieta P., Nevzorova Y.A., Nogueiras R., Macías R.I.R., Martín F., Sabio G., Soriano G., Vaquero J., Cubero F.J., Gracia-Sancho J.. Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH). Gastroenterologia y Hepatologia. 2022; 45(9)DOI:10.1016/j.gastrohep.2022.02.005. PMID:35248669. IF:1.900(Q4/10D).
01/01/2022 Risk of Immunomediated Adverse Events and Loss of Response to Infliximab in Elderly Patients with Inflammatory Bowel Disease: A Cohort Study of the ENEIDA Registry
Calafat M., Mañosa M., Ricart E., Nos P., Iglesias-Flores E., Vera I., López-Sanromán A., Guardiola J., Taxonera C., Mínguez M., Martín-Arranz M.D., de Castro L., de Francisco R., Rivero M., Garcia-Planella E., Calvet X., García-López S., Márquez L., Gomollón F., Barrio J., Esteve M., Muñoz F., Gisbert J.P., Gutiérrez A., Hinojosa J., Argüelles-Arias F., Busquets D., Bujanda L., Pérez-Calle J.L., Sicilia B., Merino O., Martínez P., Bermejo F., Lorente R., Barreiro-De Acosta M., Rodríguez C., García-Sepulcre M.F., Monfort D., Cañete F., Domènech E.. Risk of Immunomediated Adverse Events and Loss of Response to Infliximab in Elderly Patients with Inflammatory Bowel Disease: A Cohort Study of the ENEIDA Registry. Journal of Crohns & Colitis. 2022; 16(6)DOI:10.1093/ecco-jcc/jjab213. PMID:34864947. IF:8.000(Q1/2D).
01/01/2022 Baveno VII – Renewing consensus in portal hypertension
de Franchis R., Bosch J., Garcia-Tsao G., Reiberger T., Ripoll C., Abraldes J.G., Albillos A., Baiges A., Bajaj J., Bañares R., Barrufet M., Benajiba L., Berzigotti A., Bureau C., Calvaruso V., Cardenas A., D'Amico G., De Gottardi A., Dell'Era A., Escorsell A., Fallowfield J., Ferral H., Francque S., Gaba R., Garcia-Pagàn J.C., Genescà J., Rodrigues S.G., Gracia-Sancho J., Han G., Hernandez-Gea V., Jia J., Kiladjian J.J., Krag A., Laleman W., La Mura V., Lens S., Luo X., Mandorfer M., Murad S.D., Paradis V., Patch D., Piano S., Pinzani M., Plessier A., Primignani M., Procopet B., Rautou P.E., Rudler M., Sarin S.K., Schepis F., Senzolo M., Shah V., Shukla A., Tandon P., Tellez L., Thabut D., Thiele M., Trebicka J., Tripathi D., Tsochatzis E., Turco L., Turon F., Valla D., Villanueva C., Wanless I., Yoshiji H., Baveno VII Faculty. Baveno VII – Renewing consensus in portal hypertension. JOURNAL OF HEPATOLOGY. 2022; 76(4)DOI:10.1016/j.jhep.2021.12.022. PMID:35120736. IF:25.700(Q1/1D).